Jim O’Neill, President Trump’s pick to be second-in-command at HHS, has a history of working with vaccine companies and other ...
The U.K. is starting to recognize that the country needs to change how it pays for medicines to attract more pharma investment, officials said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback